The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy (original) (raw)

• Bergers G, Benjamin LE . (2003). Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3: 401–410.
  Article CAS Google Scholar
• Bottaro DP, Liotta LA . (2003). Cancer: out of air is not out of action. Nature 423: 593–595.
  Article CAS Google Scholar
• Brossay L, Chioda M, Burdin N, Koezuka Y, Casorati G, Dellabona P et al. (1998). CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med 188: 1521–1528.
  Article CAS Google Scholar
• Cox CM, D'Agostino SL, Miller MK, Heimark RL, Krieg PA . (2006). Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev Biol 296: 177–189.
  Article CAS Google Scholar
• Dai T, Ramirez-Correa G, Gao WD . (2006). Apelin increases contractility in failing cardiac muscle. Eur J Pharmacol 553: 222–228.
  Article CAS Google Scholar
• Dickson PV, Hamner JB, Sims TL, Fraga CH, Ng CY, Rajasekeran S et al. (2007). Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy. Clin Cancer Res 13: 3942–3950.
  Article CAS Google Scholar
• Dings RP, Vang KB, Castermans K, Popescu F, Zhang Y, Oude Egbrink MG et al. (2011). Enhancement of T-cell-mediated antitumor response: angiostatic adjuvant to immunotherapy against cancer. Clin Cancer Res 17: 3134–3145.
  Article CAS Google Scholar
• Eyries M, Siegfried G, Ciumas M, Montagne K, Agrapart M, Lebrin F et al. (2008). Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis. Circ Res 103: 432–440.
  Article CAS Google Scholar
• Fujii S, Shimizu K, Kronenberg M, Steinman RM . (2002). Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs. Nat Immunol 3: 867–874.
  Article CAS Google Scholar
• Fukuhara S, Sako K, Minami T, Noda K, Kim HZ, Kodama T et al. (2008). Differential function of Tie2 at cell–cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat Cell Biol 10: 513–526.
  Article CAS Google Scholar
• Gasparini G, Longo R, Toi M, Ferrara N . (2005). Angiogenic inhibitors: a new therapeutic strategy in oncology. Nat Clin Pract Oncol 2: 562–577.
  Article CAS Google Scholar
• Gerber HP, Ferrara N . (2005). Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies. Cancer Res 65: 671–680.
  CAS PubMed Google Scholar
• Gerhardt H, Betsholtz C . (2003). Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 314: 15–23.
  Article Google Scholar
• Heath VL, Bicknell R . (2009). Anticancer strategies involving the vasculature. Nat Rev Clin Oncol 6: 395–404.
  Article CAS Google Scholar
• Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W et al. (2004). Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335–2342.
  Article CAS Google Scholar
• Jain RK . (2005). Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307: 58–62.
  Article CAS Google Scholar
• June CH, Blazar BR, Riley JL . (2009). Engineering lymphocyte subsets: tools, trials and tribulations. Nat Rev Immunol 9: 704–716.
  Article CAS Google Scholar
• Kakimi K, Guidotti LG, Koezuka Y, Chisari FV . (2000). Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 192: 921–930.
  Article CAS Google Scholar
• Kälin RE, Kretz MP, Meyer AM, Kispert A, Heppner FL, Brändli AW . (2007). Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis. Dev Biol 305: 599–614.
  Article Google Scholar
• Kasai A, Shintani N, Kato H, Matsuda S, Gomi F, Haba R et al. (2008). Retardation of retinal vascular development in apelin-deficient mice. Arterioscler Thromb Vasc Biol 28: 1717–1722.
  Article CAS Google Scholar
• Kasai A, Shintani N, Oda M, Kakuda M, Hashimoto H, Matsuda T et al. (2004). Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem Biophys Res Commun 325: 395–400.
  Article CAS Google Scholar
• Kawamata Y, Habata Y, Fukusumi S, Hosoya M, Fujii R, Hinuma S et al. (2001). Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 1538: 162–171.
  Article CAS Google Scholar
• Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K et al. (1997). CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278: 1626–1629.
  Article CAS Google Scholar
• Kawano T, Nakayama T, Kamada N, Kaneko Y, Harada M, Ogura N et al. (1999). Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells. Cancer Res 59: 5102–5105.
  CAS PubMed Google Scholar
• Kidoya H, Naito H, Takakura N . (2010). Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia. Blood 115: 3166–3174.
  Article CAS Google Scholar
• Kidoya H, Ueno M, Yamada Y, Mochizuki N, Nakata M, Yano T et al. (2008). Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis. EMBO J 27: 522–534.
  Article CAS Google Scholar
• Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS et al. (1993). Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841–844.
  Article CAS Google Scholar
• Kunii N, Horiguchi S, Motohashi S, Yamamoto H, Ueno N, Yamamoto S et al. (2009). Combination therapy of _in vitro_-expanded natural killer T cells and alpha-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma. Cancer Sci 100: 1092–1098.
  Article CAS Google Scholar
• Lago F, Dieguez C, Gomez-Reino J, Gualillo O . (2007). The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev 18: 313–325.
  Article CAS Google Scholar
• Lambrecht NW, Yakubov I, Zer C, Sachs G . (2006). Transcriptomes of purified gastric ECL and parietal cells: identification of a novel pathway regulating acid secretion. Physiol Genomics 25: 153–165.
  Article CAS Google Scholar
• Lohela M, Bry M, Tammela T, Alitalo K . (2009). VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 21: 154–165.
  Article CAS Google Scholar
• Masri B, Morin N, Cornu M, Knibiehler B, Audigier Y . (2004). Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells. FASEB J 18: 1909–1911.
  Article CAS Google Scholar
• Motohashi S, Nagato K, Kunii N, Yamamoto H, Yamasaki K, Okita K et al. (2009). A phase I–II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer. J Immunol 182: 2492–2501.
  Article CAS Google Scholar
• Nieda M, Nicol A, Koezuka Y, Kikuchi A, Lapteva N, Tanaka Y et al. (2001). TRAIL expression by activated human CD4(+)V alpha 24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukemia cells. Blood 97: 2067–2074.
  Article CAS Google Scholar
• Nieda M, Okai M, Tazbirkova A, Lin H, Yamaura A, Ide K et al. (2004). Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood 103: 383–389.
  Article CAS Google Scholar
• Padera TP, Stoll BR, Tooredman JB, Capen D, di Tomaso E, Jain RK . (2004). Pathology: cancer cells compress intratumour vessels. Nature 427: 695.
  Article CAS Google Scholar
• Rosenberg SA, Lotze MT, Yang JC, Aebersold PM, Linehan WM, Seipp CA et al. (1989). Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Ann Surg 210: 474–484; discussion 484–475.
  Article CAS Google Scholar
• Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME . (2008). Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer 8: 299–308.
  Article CAS Google Scholar
• Seaman S, Stevens J, Yang MY, Logsdon D, Graff-Cherry C, St Croix B . (2007). Genes that distinguish physiological and pathological angiogenesis. Cancer Cell 11: 539–554.
  Article CAS Google Scholar
• Seino K, Fujii S, Harada M, Motohashi S, Nakayama T, Fujisawa T et al. (2005). Valpha14 NKT cell-mediated antitumor responses and their clinical application. Springer Semin Immunopathol 27: 65–74.
  Article CAS Google Scholar
• Shin T, Nakayama T, Akutsu Y, Motohashi S, Shibata Y, Harada M et al. (2001). Inhibition of tumor metastasis by adoptive transfer of IL-12-activated Valpha14 NKT cells. Int J Cancer 91: 523–528.
  Article CAS Google Scholar
• Singh AK, Wilson MT, Hong S, Olivares-Villagomez D, Du C, Stanic AK et al. (2001). Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med 194: 1801–1811.
  Article CAS Google Scholar
• Smyth MJ, Crowe NY, Pellicci DG, Kyparissoudis K, Kelly JM, Takeda K et al. (2002). Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. Blood 99: 1259–1266.
  Article CAS Google Scholar
• Sorhede Winzell M, Magnusson C, Ahren B . (2005). The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice. Regul Pept 131: 12–17.
  Article Google Scholar
• Sorli SC, Le Gonidec S, Knibiehler B, Audigier Y . (2007). Apelin is a potent activator of tumour neoangiogenesis. Oncogene 26: 7692–7699.
  Article CAS Google Scholar
• Spada FM, Koezuka Y, Porcelli SA . (1998). CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med 188: 1529–1534.
  Article CAS Google Scholar
• Steinman RM, Banchereau J . (2007). Taking dendritic cells into medicine. Nature 449: 419–426.
  Article CAS Google Scholar
• Takakura N, Watanabe T, Suenobu S, Yamada Y, Noda T, Ito Y et al. (2000). A role for hematopoietic stem cells in promoting angiogenesis. Cell 102: 199–209.
  Article CAS Google Scholar
• Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao H . (2003). The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu Rev Immunol 21: 483–513.
  Article CAS Google Scholar
• Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX et al. (1998). Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 251: 471–476.
  Article CAS Google Scholar
• Willett CG, Kozin SV, Duda DG, di Tomaso E, Kozak KR, Boucher Y et al. (2006). Combined vascular endothelial growth factor-targeted therapy and radiotherapy for rectal cancer: theory and clinical practice. Semin Oncol 33: S35–S40.
  Article CAS Google Scholar
• Yamada Y, Takakura N . (2006). Physiological pathway of differentiation of hematopoietic stem cell population into mural cells. J Exp Med 203: 1055–1065.
  Article CAS Google Scholar